Journal article
Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In‐hospital and six‐month outcomes
Abstract
Abciximab is effective for the prevention of complications when administered prior to percutaneous coronary intervention (PCI). The efficacy and safety of abciximab as an unplanned or rescue agent for complications of PCI is unknown. Rescue versus planned use was compared in 186 consecutive patients. Primary or rescue PCI for acute myocardial infarction (MI) and shock were excluded. Rescue abciximab use was undertaken in 101 patients (54.3%) …
Authors
Velianou JL; Strauss BH; Kreatsoulas C; Pericak D; Natarajan MK
Journal
Catheterization and Cardiovascular Interventions, Vol. 51, No. 2, pp. 138–144
Publisher
Wiley
Publication Date
October 2000
DOI
10.1002/1522-726x(200010)51:2<138::aid-ccd2>3.0.co;2-u
ISSN
1522-1946